Center-Authored Papers

Filters: Author is Fife, Kenneth H  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E et al..  2012.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.. The New England journal of medicine. 367(5):399-410. Abstract
C
Mujugira A, Baeten JM, Donnell D, Ndase P, Mugo NR, Barnes L, Campbell JD, Wangisi J, Tappero JW, Bukusi E et al..  2011.  Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention.. PloS one. 6(10):e25828. Abstract
D
Lingappa JR, Baeten JM, Wald A, Hughes JP, Thomas KK, Mujugira A, Mugo N, Bukusi EA, Cohen CR, Katabira E et al..  2010.  Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.. Lancet. 375(9717):824-33. Abstract
Mujugira A, Magaret AS, Celum C, Baeten JM, Lingappa JR, Morrow RA, Fife KH, Delany-Moretlwe S, de Bruyn G, Bukusi EA et al..  2013.  Daily Acyclovir to Decrease Herpes Simplex Virus Type 2 (HSV-2) Transmission from HSV-2/HIV-1 Coinfected Persons: A Randomized Controlled Trial.. The Journal of infectious diseases. Abstract
Celum C, Morrow RA, Donnell D, Hong T, Hendrix CW, Thomas KK, Fife KH, Nakku-Joloba E, Mujugira A, Baeten JM.  2014.  Daily Oral Tenofovir and Emtricitabine-Tenofovir Preexposure Prophylaxis Reduces Herpes Simplex Virus Type 2 Acquisition Among Heterosexual HIV-1-Uninfected Men and Women: A Subgroup Analysis of a Randomized Trial.. Annals of internal medicine. 161(1):11-9. Abstract
E
Magaret AS, Mujugira A, Hughes JP, Lingappa J, Bukusi EA, de Bruyn G, Delany-Moretlwe S, Fife KH, Gray GE, Kapiga S et al..  2015.  Effect of Condom Use on Per-act HSV-2 Transmission Risk in HIV-1, HSV-2-discordant Couples.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. Abstract
F
Ndase P, Celum C, Kidoguchi L, Ronald A, Fife KH, Bukusi E, Donnell D, Baeten JM.  2015.  Frequency of False Positive Rapid HIV Serologic Tests in African Men and Women Receiving PrEP for HIV Prevention: Implications for Programmatic Roll-Out of Biomedical Interventions.. PloS one. 10(4):e0123005. Abstract
H
Baeten JM, Lingappa J, Beck I, Frenkel LM, Pepper G, Celum C, Wald A, Fife KH, Were E, Mugo N et al..  2011.  Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons.. The Journal of infectious diseases. 203(1):117-21. Abstract
O
Ndase P, Celum C, Thomas K, Donnell D, Fife KH, Bukusi E, Delany-Moretlwe S, Baeten JM.  2012.  Outside Sexual Partnerships and Risk of HIV Acquisition for HIV Uninfected Partners in African HIV Serodiscordant Partnerships.. Journal of acquired immune deficiency syndromes. 59(1):65-71. Abstract
P
Lingappa J, Thomas KK, Hughes JP, Baeten JM, Wald A, Farquhar C, de Bruyn G, Fife KH, Campbell MS, Kapiga S et al..  2013.  Partner characteristics predicting HIV-1 setpoint in sexually acquired HIV-1 among African seroconverters.. AIDS research and human retroviruses. 29(1):164-71. Abstract
T
Fife KH, Mugwanya K, Thomas KK, Baeten JM, Celum C, Bukusi E, de Bruyn G, Mujugira A, Vwalika B, Wald A et al..  2015.  Transient Increase in HSV-2-Associated Genital Ulcers Following Initiation of Antiretroviral Therapy in HIV-1/HSV-2 Co-Infected Individuals.. The Journal of infectious diseases. Abstract
U
Kahle EM, Kashuba A, Baeten JM, Fife KH, Celum C, Mujugira A, Essex M, de Bruyn G, Wald A, Donnell D et al..  2014.  Unreported Antiretroviral Use by HIV-1-Infected Participants Enrolling in a Prospective Research Study.. Journal of acquired immune deficiency syndromes (1999). 65(2):e90-4.